- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01154608
Effect of Enzyme Therapy on Protein Metabolism in Chronic Pancreatitis
June 30, 2010 updated by: Institut National de la Recherche Agronomique
Pancreatic exocrine insufficiency is known to impair nutrient absorption, especially fat, but few data exist about protein absorption.
We aimed to investigate this question and assess the enzyme substitution efficiency using a sensitive method.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
11
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Bobigny, France, 93000
- Centre de recherche sur volontaires
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Chronic pancreatitis
- Pancreatic insufficiency
- Enzyme therapy treatment
Exclusion Criteria:
- Hepatic failure
- Pregnancy
- Positive serology to HIV, HCV, AGHbS, gastro-intestinal disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: pancreatic enzymes
|
|
Placebo Comparator: control
|
Current enzyme therapy of the patient is stopped during 7 days
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
transfer of dietary nitrogen to metabolic pools
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2005
Study Registration Dates
First Submitted
June 30, 2010
First Submitted That Met QC Criteria
June 30, 2010
First Posted (Estimate)
July 1, 2010
Study Record Updates
Last Update Posted (Estimate)
July 1, 2010
Last Update Submitted That Met QC Criteria
June 30, 2010
Last Verified
May 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PANCREATITE
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pancreatitis
-
Changhai HospitalUnknownChronic Pancreatitis | Idiopathic Chronic PancreatitisChina
-
Centre Hospitalier Universitaire de NiceRecruiting
-
Tianjin Nankai HospitalCompletedAcute PancreatitisChina
-
Copenhagen University Hospital, HvidovreRecruitingFibrosis | Inflammation | Pancreatitis | Chronic Pancreatitis | Acute Pancreatitis | Recurrent PancreatitisDenmark
-
Massachusetts General HospitalTerminatedChronic Pancreatitis | Acute Recurrent PancreatitisUnited States
-
Changhai HospitalEnrolling by invitationChronic Pancreatitis | Acute Pancreatitis | Healthy PeopleChina
-
Postgraduate Institute of Medical Education and...Completed
-
Dartmouth-Hitchcock Medical CenterCompleted
-
The Cleveland ClinicChiRhoClin, Inc.; The National Pancreas FoundationCompletedChronic PancreatitisUnited States
Clinical Trials on Creon
-
AbbottCompletedPancreatic Exocrine Insufficiency Due to Cystic FibrosisHungary, Spain
-
AbbottRecruiting
-
AbbottDatamap; ClinIntel; Catalent; NuvisanWithdrawnExocrine Pancreatic Insufficiency in Subjects With Diabetes Mellitus Type 2Germany, Spain
-
AbbVieCompleted
-
AbbottAbbVie; Parexel; Datamap; LKF Laboratorium für Klinische Forschung GmbH; Analytical... and other collaboratorsCompletedExocrine Pancreatic Insufficiency in Subjects With Cystic FibrosisSpain, Czech Republic, Hungary, Poland
-
Abbott ProductsCompletedPancreatic Exocrine InsufficiencyRussian Federation
-
Hospital AvicenneSolvay PharmaceuticalsCompleted
-
Abbott ProductsQuintiles, Inc.; Data Map GmbHCompleted
-
Vanderbilt University Medical CenterEnrolling by invitationType 1 DiabetesUnited States
-
Sheffield Teaching Hospitals NHS Foundation TrustTerminatedPatients With Coeliac Disease and Chronic Diarrhoea (>3 Loose/ Liquid Motions a Day for More Than 4 Weeks) | Patients With Pancreatic Exocrine InsufficiencyUnited Kingdom